Snipr Biome Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 48

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $40.8M

  • Investors
  • 7

Snipr Biome General Information

Description

Developer of clustered regularly interspaced short palindromic repeats-based medicines designed to revolutionize the treatment of microbial diseases. The company's medicines utilize the adaptive immune system in a programmable way to kill target bacteria based on their specific genomes, enabling health professionals to access targeted microbiome engineering.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Lersø Parkallé 44
  • 2100 Copenhagen
  • Denmark
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • Lersø Parkallé 44
  • 2100 Copenhagen
  • Denmark

Snipr Biome Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Snipr Biome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series B) 07-Aug-2025 $40.8M Completed Generating Revenue
7. Debt - General 21-Oct-2024 Completed Generating Revenue
6. Accelerator/Incubator 22-Apr-2024 Completed Generating Revenue
5. Grant Completed Clinical Trials - Phase 1
4. Grant 27-May-2021 Completed Clinical Trials - Phase 1
3. Later Stage VC 31-Dec-2020 Completed Clinical Trials - Phase 1
2. Later Stage VC (Series A) 11-Mar-2019 $50M $52.9M Completed Clinical Trials - Phase 1
1. Seed Round $2.93M $2.93M Completed Clinical Trials - Phase 1
To view Snipr Biome’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Snipr Biome Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of clustered regularly interspaced short palindromic repeats-based medicines designed to revolutionize the tre
Drug Discovery
Copenhagen, Denmark
48 As of 2026

Cambridge, MA
 

Paris, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Snipr Biome Competitors (44)

One of Snipr Biome’s 44 competitors is Vedanta Biosciences, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vedanta Biosciences Venture Capital-Backed Cambridge, MA
Eligo Bioscience Venture Capital-Backed Paris, France
PEP-Therapy Venture Capital-Backed Evry Cedex, France
Enterome Venture Capital-Backed Paris, France
4D pharma Corporation Leeds, United Kingdom
You’re viewing 5 of 44 competitors. Get the full list »

Snipr Biome Patents

Snipr Biome Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026234106-A1 Engineered microbial cells producing a dopamine precursor for use in treating neurologal diseases Pending 07-May-2025
GB-202506982-D0 Medicaments, compositions & methods Pending 07-May-2025
GB-202505570-D0 Promoting colonisation using rare carbohydrates Pending 14-Apr-2025
GB-202505572-D0 Promoting colonisation using rare carbohydrates Pending 14-Apr-2025
WO-2026219859-A2 Promoting colonisation using rare carbohydrates Pending 14-Apr-2025 C12N1/20
To view Snipr Biome’s complete patent history, request access »

Snipr Biome Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Snipr Biome Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cystic Fibrosis Foundation Limited Partner Minority
SPRIN-D Government Minority
CARB-X University Minority
EQT Life Sciences Venture Capital Minority
Lundbeckfonden BioCapital Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Snipr Biome FAQs

  • When was Snipr Biome founded?

    Snipr Biome was founded in 2011.

  • Where is Snipr Biome headquartered?

    Snipr Biome is headquartered in Copenhagen, Denmark.

  • What is the size of Snipr Biome?

    Snipr Biome has 48 total employees.

  • What industry is Snipr Biome in?

    Snipr Biome’s primary industry is Drug Discovery.

  • Is Snipr Biome a private or public company?

    Snipr Biome is a Private company.

  • What is Snipr Biome’s current revenue?

    The current revenue for Snipr Biome is .

  • How much funding has Snipr Biome raised over time?

    Snipr Biome has raised $136M.

  • Who are Snipr Biome’s investors?

    Cystic Fibrosis Foundation, SPRIN-D, CARB-X, EQT Life Sciences, and Lundbeckfonden BioCapital are 5 of 7 investors who have invested in Snipr Biome.

  • Who are Snipr Biome’s competitors?

    Vedanta Biosciences, Eligo Bioscience, PEP-Therapy, Enterome, and 4D pharma are some of the 44 competitors of Snipr Biome.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process